| NCT ID | NCT07434583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Laryngeal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-02 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-01-02 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is to understand more about the forces that are involved on the tongue and other oropharyngeal structures during laryngeal surgery. This information will be used to determine if these forces can affect outcomes (pain, numbness, taste, etc) and whether factors such as procedure type, surgeon experience (i.e. resident, fellow, attending), and choice of surgical equipment affect these forces. This information may be used to reduce these forces and prevent these issues from happening during certain laryngeal surgeries. For the first 50 patients, force measurements will be taken and correlated to outcome measures . Surgeons will be blinded to the force measurements intra-operatively. For the next 50 patients, surgeons will be given force measurements in real-time intra-operatively allowing adjustments to be made. The impact of this adjustment on outcomes will be determined.
Eligibility Criteria
Inclusion Criteria: * \>18 years old with * undergoing laryngeal surgery with direct laryngoscopy Exclusion Criteria: * Prior history of tongue dysfunction such as glossectomy (hemi or total) or hypoglossal nerve injury * Patient inability to follow up after initial procedure
Contact & Investigator
Tyler Crosby, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07434583 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Laryngeal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07434583 currently recruiting?
Yes, NCT07434583 is actively recruiting participants. Contact the research team at riley.jackson@ucsf.edu for enrollment information.
Where is the NCT07434583 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07434583 clinical trial?
NCT07434583 is sponsored by University of California, San Francisco. The principal investigator is Tyler Crosby, MD at University of California, San Francisco. The trial plans to enroll 100 participants.